Identification

Listing sponsor / Agent
Integrae SIM
Symbol
PRE
ISIN code
IT0005611071
Code LEI
8156002D92B96450A045
Exchange / Market
Euronext Growth
Trading location
Milan
ICB
20102010 Medical Equipment
Website address
https://www.predictcare.it/

Operation

IPO date
Seg 30/09/2024
IPO price
€1.00
IPO type
Private placement

Perfil da Empresa

Predict S.p.A. specialises in the design, development and marketing of innovative systems in the fields of medical imaging and medical technology. Net sales break down by activity as follows:
  • sale of diagnostic imaging systems (94.6%): ultrasound, X-ray and magnetic resonance imaging equipment used in gynaecology, cardiology, general imaging and mammography;
  • support services (16.1%): including technical assistance and professional training in the field of medical imaging;
  • development of telemedicine technology solutions using augmented reality, robotics and holography (7.4%; Optip and Aphel);
  • sale of diagnostic systems based on breath analysis (4.3%; Mistral);
  • other (0.4%).
Italy accounts for all sales.

Fonte: Cofisem - Última atualização: 25 Mar 2025
Principais Executivos
Chairman and Chief Executive Officer Angelo Aurelio Gigante
Head of Investor Relations Angelo Aurelio Gigante
Fonte: Cofisem - Última atualização: 25 Mar 2025
Números principais
Millenium 2024 2023 2022 2021
Net sales 6.626 7.190.011 5.479.825 4.287.797
Consumed purchases 3.974 4.604.556 3.175.244 2.647.357
Labour costs 1.149 1.246.016 1.062.068 879.590
Operating profit 514 328.398 288.441 331.273
Income tax 139 106.409 95.703 76.836
Net income 336 190.569 166.798 248.003
Net income (Group share) 190.569 166.798 248.003
Fiscal year end 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Length of fiscal year (month) 12 12 12 12
Currency & Unit EUR - thousands EUR - unit EUR - unit EUR - unit
Account Standards Local GAAP Local GAAP Local GAAP Local GAAP
Fonte: Cofisem - Última atualização: 25 Mar 2025
Informação Acionistas
Qo3 S.r.l. 71,96 %
Free float 28,04 %
Fonte: Cofisem - Última atualização: 25 Mar 2025